Advertisement

Topics

Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase ...

13:00 EDT 14 Mar 2018 | BioMedReports - Blog

LAU-7b is a once-a-day oral pro-resolving therapy with potential to treat chronic pulmonary inflammation that leads to irreversible lung damage in patients with CF, regardless

Read more...

Original Article: Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase ...

NEXT ARTICLE

More From BioPortfolio on "Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...